Mindset Pharma announced that under its Co-operative Psychedelics Evaluation Platform (COPE) further developed its first-generation psychedelics benchmarking data by establishing standard pharmacokinetic, brain penetration, and drug discrimination data and protocols across LSD, psilocybin, and 5-MeO-DMT.
Category Scientific / Research
Published in BioSpace
Companies Featured
Mindset PharmaMindset Pharma is a Toronto-based drug discovery company that aims to develop novel psychedelic drugs.